Multi-Center Study Safety of Adipose Derived Mesenchymal Stem Cells for the Treatment of Multiple Sclerosis
Clinical trial NCT02326935 · TERMINATED
Trial details
- NCT number
- NCT02326935
- Sponsor
- American CryoStem Corporation
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-11-01
- Primary completion
- 2018-05-18
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.